Celgene said to be near $7 billion deal to buy Impact Biomedicines
January 07, 2018 at 18:14 PM EST
Celgene Corp. is nearing a deal to buy biotechnology company Impact Biomedicines for as much as $7 billion, according to people familiar with the matter.